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Abstract Genetic counseling services have existed in Israel
since 1964 and are available in almost all the major hospitals.
Given the socialized healthcare system and small country size,
genetic services are generally accessible and often free. The
existence of founder mutations in various communities in Israel
makes genetic testing easier to perform. Yet, the ethnic, cultural
and religious diversity of the population has major implications
on the design of the screening programs and the use of genetic
services. The Israeli Association of Genetic Counselors (IAGC)
was established in 2008 and had existed informally since 1989.
There are two Master level genetic counseling training pro-
grams (6 students/class, 2 year program): Hebrew University-
Hadassah Medical School (established in 1997) and the
Technion (established in 2009). Genetic counselors’ clinical
training is largely observational and 2 years of supervised
counseling sessions post degree are required for board exam
eligibility. Genetic counselors are licensed and lead counseling
sessions individually, but currently must work under medical
geneticist supervision. This is the first article to summarize the
history and training ofMaster level genetic counselors in Israel.
Genetic services, coverage and regulations are also described.
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Introduction
Genetic counseling is practiced in all the major hospitals in
Israel, covering a wide range of indications and applications
from preimplantation genetic diagnosis to predictive testing.
Providing genetic counseling in Israel presents both oppor-
tunities and challenges. The small size of the country ena-
bles patients to access genetic services without having to
travel far. Israel has a socialized healthcare system, which
results in availability and coverage of most genetic services
for the general population.
Israel has a population of about 7.5 million citizens, with
76 % Jews, 20 % Arabs (including Bedouins) and 4 % other
small groups (Central Bureau of Statistics 2011). Each
group is heterogeneous within itself, the Jews according to
the country of origin from which they immigrated to Israel
(Cohen et al. 2004) and the Arabs according to the region of
the country or even the village in which they live (Jaber et
al. 2000). The precise origin is particularly important when
providing genetic counseling and genetic testing, since in
each subgroup some hereditary disorders have been reported
with an increased frequency (Zlotogora and Chemke 1995).
Genetic research, carried out by Israeli geneticists in the
various communities, has resulted in the availability of tests
for more genetic disorders (Rosner et al. 2009). However,
the widespread application of these advances is limited due
to complex cultural and religious issues that have significant
implications for genetic counseling and use of genetic
testing.
Genetic counseling by non-physicians has been practiced
in Israel almost 40 years. There are two genetic counseling
training programs and the first program was established in
1997. Medical genetic services provided in Israel include a
wide range of screening and diagnostic testing, and genetic
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counselors are involved in most of these activities. Yet, there
are barriers that prevent genetic counselors from expanding
their services and improving their professional status. This
article describes clinical genetic services in Israel and fo-
cuses on the training and services provided by genetic
counselors, as well as the challenges they face.
History
The first genetics clinic, which in fact was called the
“Genetic Counseling Clinic” opened in 1964 in Jerusalem
at Hadassah University Medical Center, Department of
Human Genetics. Medical Genetics has been recognized
as a medical specialty by the Israeli Medical Association
and the Ministry of Health since 1986. Physicians certi-
fied in internal medicine, pediatrics or obstetrics and
gynecology could undergo 2-years of training and take
a board examination to become certified in medical ge-
netics (Chemke and Zlotogora 1997). Since 2010, physi-
cians certified in any specialty can undergo training in
medical genetics.
Genetic counseling by non-physicians has been practiced
in Israel since the early 1970’s, first by graduates of Sarah
Lawrence College (United States) who moved to the coun-
try and also by a few MSc’s and PhD’s in Genetics, who
received their degrees in Israel. Given advances in genetics
in the 1980s and 1990s, there was an increasing need for
genetic counseling services and more MSc’s and PhD’s in
genetics or human genetics, as well as a few more graduates
of US programs, provided these services. The number of
genetic counseling providers and approach to providing
services changed significantly when graduates from
Israel’s genetic counseling training programs joined the
workforce beginning in the late 1990s.
An association of genetic counselors was established in
1989 with the main goal of providing continuing education
at biannual meetings. In 2008, efforts of a group of genetic
counselors successfully resulted in the association being
registered by the Israeli Corporation Authority at the The
Ministry of Justice as “The Israeli Association of Genetic
Counselors” (IAGC), with a much broader agenda and
activities. The aims of this new professional organization
were announced as: Advancing the professional status of
genetic counselors, improving their employment conditions
and salaries; regulating licensure of genetic counselors;
advancing the status of the profession; enhancing public
awareness and accessibility to genetic services (www.
genetic-counselors.org.il/about.asp). Facilitating genetic
counselors’ participation in writing the board exam with
the head of the Department of Community Genetics in the
Ministry of Health, accomplished in 2008, was the first
achievement of the new association. In 2009, efforts of the
IAGC resulted in the Ministry of Health’s recognition of
“genetic counselor” as one of the para-medical professions.
Israeli Health Care System and Coverage of Genetic
Services
The National Health Insurance Law, passed in 1995 and
updated annually, provides for a standardized “basket of
services” (inpatient and outpatient diagnostic procedures,
treatments, medications and hospitalizations) for all resi-
dents of Israel (www.mfa.gov.il/MFA). A mandatory month-
ly health insurance tax is paid by residents. Supplemental
insurance that provides more extensive coverage can be
purchased. Genetic counseling is included in the basic bas-
ket, and many, but not all genetic tests are covered.
The National Program for the Detection and Prevention of
Birth Defects, established by the Ministry of Health in 1980,
(Chemke and Zlotogora 1997) covers screening of high-risk
populations (defined as having a carrier frequency of a
particular disease of at least 1:60), newborn screening and
prenatal diagnosis. Free genetic screening is provided for
several genetic diseases (currently: Tay-Sachs, cystic fibro-
sis, familial dysautonomia and thalassemia) (www.health.
gov.il/Subjects/pregnancy/before_pregnancy/genetic). More
extensive screening, including Fragile X syndrome, spinal
muscular atrophy (SMA) and other selected autosomal re-
cessive diseases, is offered with coverage shared between the
patient and the supplementary insurance (Berkenstadt et al.
2007; Rosner et al. 2009). In 2002, the Ministry of Health
expanded the free-of-charge health basket to include a tar-
geted carrier screening program directed at the communities
in which severe genetic diseases are present with a frequency
higher than 1/1000 live births. As there are no known genetic
diseases with such a high frequency in any of the Jewish
communities, the program targets the Arab, Druze and
Bedouin populations (Zlotogora et al. 2009a), who live
mostly in villages and have a very high rate of consanguin-
eous marriages. Genetic counseling must accompany results
disclosure for those who are found to be carriers.
The Jewish ultra-orthodox religious community uses a
separate system for carrier screening, managed by the inter-
national organization Dor Yeshorim (http://webexposite.
com/preview/dor_yeshorim/). Since in this community, mar-
riages are arranged by the parents and termination of preg-
nancy is generally banned, the purpose of this program is to
prevent marriages of two carriers (Bach et al. 2007). Testing
high school students and young adults is done anonymously,
without any genetic counseling (Sagi 1998). The only infor-
mation communicated is whether the potential match is
“suitable” (meaning that the potential couple does not carry
mutations in the same gene) and actual test results are not
disclosed.
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Standard screening during pregnancy, for the detection of
Down syndrome and other birth defects, including first
trimester screening, triple test and ultrasound screenings
are covered. Chorionic villus sampling and amniocentesis
are free of charge if the woman 1) is age 35 or older 2) has a
1 in 380 or greater risk on a first or second trimester
screening test or 3) has a high risk for a genetic disorder.
Preimplantation genetic diagnosis (PGD) is fully covered
for couples at risk to have children affected with a serious
genetic disease or for carriers of chromosome rearrange-
ments. There is national newborn screening in Israel, cov-
ered by the Ministry of Health, which was updated in 2009
to include 12 severe diseases that are treatable and are not
detected by carrier screening programs (www.health.gov.il/
Subjects/Genetics/newborn_neonatal_screening).
Genetic Services in Israel
Medical Genetics Centers that include clinics and laborato-
ries (cytogenetic and molecular) are found in 16 hospitals,
which are almost all of the major hospitals in Israel. As of
June 2012, there are approximately 40 medical geneticists
(personal communication), 50 certified genetic counselors
and 10 genetic counselors in practicum (records of The
Israeli Association of Genetic Counselors, 2012).
Genetic counseling providers use a non-directive ap-
proach. Because of the cultural and religious diversity of
the Israeli society, genetic counselors are trained to respect
both high demanding/highly aware individuals/couples, as
well as those who reject the service (particularly prenatal
diagnosis) due to religious or cultural reasons. Most genetic
counseling sessions are conducted in Hebrew, and rarely in
English. Unfortunately, there is a serious lack of Arabic
speaking genetic counselors, which significantly impacts
communication between counselors and Palestinian women,
who usually do not speak Hebrew. Frequently, Palestinian
women come to the clinics accompanied by either their hus-
bands or relatives, who do speak Hebrew. Israel also has a
number of immigrants from different countries (especially
from the former USSR and Ethiopia); language barriers exist
because interpreters are not always available in hospitals.
For more than a decade, genetic counselors’ provision of
counseling after prenatal abnormal findings (detected by
screening or ultrasound) has been a major component of
their work. Cancer genetic counseling also has become a
major area of practice and is provided mainly by genetic
counselors. Given the high incidence of BRCA1/2 mutation
carriers among Ashkenazi Jews (Abeliovich et al. 1997;
Levy-Lahad et al. 1997) and the existence of founder muta-
tions in Ashkenazi, Sephardic and Middle Eastern Jews
(Sagi et al. 2011; Shiri-Sverdlov et al. 2001), genetic testing
is widely used by women with a personal or family history
of breast and/or ovarian cancer. In 2012, BRCA1/2 sequenc-
ing was added to services covered by Health Plans in cases
where the chance of finding a mutation in one of these genes
is predicted to be at least 10 % (according to specified risk
calculation software). Testing for the three Ashkenazi
Jewish founder mutations in the HNPCC genes is also
available (Goldberg et al. 2008).
Genetic carrier screening is provided based on the cou-
ple’s ethnicity. The scope of genes recommended for testing
in the Jewish population is periodically updated, by the
Association of Medical Geneticists and by the Ministry of
Health, according to the ongoing identification of founder
mutations. In the Arab, Druze and Bedouin populations,
multiple founder mutations are generally screened for, at
the level of specific villages or even tribes (Zlotogora et
al. 2009b). The National and Ethnic Mutation Databases
(NEMDBs) are continuously updating mutation depositories
that contain extensive information on the described genetic
heterogeneity found in the Jewish and non-Jewish popula-
tions in Israel (Available at: www.goldenhelix.org/israeli).
The Israeli National Genetic Database was launched in 2006
to improve knowledge of genetic disorders and their occur-
rence in the various ethnic groups in the Israeli population
for clinical purposes, genetic counseling and research
(Zlotogora et al. 2007b).
Acceptance of Genetic Services
The diversity of the Israeli population, in terms of culture
and religion, impacts the acceptance of genetic services.
There is a significant association between the religious
observance women practice and the performance of various
genetic tests. For example, a study carried out in the Jewish
population showed that 94.4 % of secular women over age
35 had prenatal diagnosis, while 36.4 % of religious and
none of the ultra-religious women had this test (Sher et al.
2003). In the Arab population, acceptance of prenatal diag-
nosis is higher among Christians (58 %) than among
Muslims (15 %), reflecting differing views towards preg-
nancy termination (Zlotogora et al. 2007a). Carrier screen-
ing is widely utilized by Israeli couples, mainly for the
diseases covered by the Ministry of Health but also elective-
ly for Fragile X syndrome (Berkenstadt et al. 2007), SMA
(Ben-Shachar et al. 2011), several other Mendelian conditions
for which testing is recommended by The Israeli Association
of Medical Geneticists, and also Gaucher Disease, even
though testing is not recommended by this professional soci-
ety (Zuckerman et al. 2007).
Regulation of Genetic Services
The Ministry of Health is responsible for the regulation of
the health system, including genetic services. The Ministry
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of Health issues guidelines on different aspects of ge-
netic testing and screening. For example: required stand-
ards for genetic laboratories, eligibility for covered
amniocentesis, recommended screening for Down syn-
drome. These guidelines frequently are based on recom-
mendations of professional organizations, such as the
National Council for Gynecology, Neonatology and
Genetics or the Association of Medial Geneticists.
Termination of Pregnancy
Abortion in Israel is subject by law to the legal approval
of a ‘committee for pregnancy termination’ that is autho-
rized to grant abortion requests. Up to week 24, the
committee is composed of two physicians (one has to
be a gynecologist) and a social worker. At least one of
the committee members has to be a woman. Abortions
are approved for various indications, including a risk for
the newborn to have a physical or mental disability
(Book of Laws, 1977). Late terminations, up to term,
must be approved by a larger committee, composed of
the heads of the medical center, department of obstetrics
and gynecology, department of neonatology, a senior
social worker and the head of the genetics department.
A risk higher than 30 % for a serious disability has to be
estimated for approval of late terminations (www.health.
gov.il/hozer/mk23_2007.pdf).
Genetic Information Law
The Israel Parliament passed a Genetic Information Law
in December 2000 (Genetic Information Law, 5761-
2000, Book of Laws). The law bans employers and
insurers from asking a person to provide genetic infor-
mation or to undergo genetic testing and prohibits them
from making use of results of such testing. The law also
defines who is qualified to provide genetic counseling: a
medical geneticist, a genetic counselor and a specialist
medical practitioner (e.g. neurologist, oncologist). In
addition, the law defines the appropriate qualifications
required for each of the specialists who provide genetic
counseling.
Licensure of Genetic Counselors
Since 2008, the Ministry of Health has administered a
board exam yearly that all candidates must pass to be
eligible for a license; genetic counselors take a different
exam than medical geneticists. Before 2008, licenses
were issued to individuals who had practiced genetic
counseling for at least 3 years and had graduated from
genetic counseling programs or had an MSc or PhD
degree in Genetics or Human Genetics. Currently, in
order to be eligible for the licensure exam, a genetic
counselor must first work under the supervision of a
medical geneticist and/or licensed genetic counselor in a
clinic at a genetics center for 2 years and submit a
logbook of 85 cases representing all areas of counsel-
ing. Genetic counseling sessions are observed in the
beginning and later the relationship becomes more of a
consultation, with a senior genetic counselor or a med-
ical geneticist signing all their counseling letters.
Subsequent to passing the board exam, the genetic coun-
selor can obtain a lifetime license from the Ministry of
Health; recertification and documentation of continuing ed-
ucation are not required. Until a license is granted, the
graduate is considered a trainee (in practicum) and is not
regarded as a “genetic counselor.”
Genetic Counselor Training
There are two Master’s Degree genetic counseling train-
ing programs in Israel: Hebrew University-Hadassah
Medical School, Jerusalem (established in 1997) and
the Technion (Israel Institute of Technology), Haifa
(established in 2009). Both are 2-year programs with
one class of 6 students at a time, due to limitations in
staff and clinic rotation sites. As of June 2012, there
have been 51 graduates (45 from the Hebrew University
and 6 from the Technion). Most of the graduates have
remained in Israel to provide genetic counseling
services.
The following sections will describe the training pro-
vided in the longer-standing program at the Hebrew
University- Hadassah Medical School, which author
Michal Sagi directs. This genetic counseling training
program involves a combination of coursework and
clinical training with an option to do research and
complete a thesis.
Acceptance to the Program
Students have usually completed 2-years of army service
and 3 years of university studies prior to enrollment in the
program. Most students have a Bachelor of Science degree
(BSc) in Biology or Medical Sciences; the few who have a
Bachelor degree in Psychology have to take a year of
supplementary studies in Biology. Very high grades in un-
dergraduate studies are a prerequisite for applying to the
program and applicants have to submit their CV and a letter
that summarizes their motivation to enter the program. After
applications are reviewed by a team of genetic counselors
and a medical geneticist faculty member, 30–40 % of the
applicants are invited for an interview. The acceptance rate
is about 15–20 % of the total applications.
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Coursework, Clinical Work and Thesis
The current coursework and clinical training for genetic
counseling students is listed in Table 1. About 80 % of the
courses are taken together with other MSc or PhD students;
about 25 % of these courses were originally designed for
genetic counseling students and later offered to other grad-
uate students. Each year students spend two months,
3–4 days a week, in genetics clinics; one month at
Hadassah Medical Center and one month split between two
other hospitals (Table 1). If students decide to do a research
thesis, they will typically graduate 4–6 months later. Most of
the projects have been performed in research laboratories
and very few are epidemiological or psychosocial projects;
most of the mentors are not program faculty. Completion of a
research thesis is a prerequisite for any PhD program, and
generally most students wish to have this option for their
careers. In fact, almost all the graduates to date have com-
pleted a research project and about one-third of the graduates
have continued their studies for a PhD degree, either directly
after graduating from the genetic counseling program or after
a few years of working as genetic counselors.
The Profile of Genetic Counselors
As in December 2012, there are 60 genetic counselors working
in Israel (including those in practicum). All genetic counselors
to date have been females, except for one male. Twenty-five
(41.7 %) graduated from a genetic counseling program in
Israel and 6 (10.0 %) graduated from programs in the United
States, 16 (26.7 %) have an MSc in Genetics/Human Genetics
and 13 (21.7 %) have a PhD in Genetics/Human Genetics (3 of
the 13 are also graduates of the genetic counseling program in
Jerusalem). Genetic counselors with a PhD generally are not in
research positions; they have similar positions as genetic
counselors with a Master degree but may have more supervis-
ing and teaching responsibilities.
Status of Genetic Counselors
In most clinics, genetic counselors independently counsel
patients for 1–2 h sessions and refer patients for prenatal
diagnosis, carrier testing and other tests, consulting the med-
ical geneticist only when necessary. However, this indepen-
dence in providing genetic counseling services is not
recognized in current legislation. Genetic counselors are li-
censed in Israel but are not considered an independent profes-
sion. In 2005, the Ministry of Health, stipulated that genetic
counselors have to work in a genetics clinic under the super-
vision of a medical geneticist. This guideline has significantly
limited the job options for genetic counselors, both in hospi-
tals and community clinics and restricted their working with
non-geneticists. While genetic counselors can work with non-
geneticists, such as oncologists or gynecologists, a medical
Table 1 Coursework and clini-
cal training of genetic counsel-
ing students in the Hebrew
University – Hadassah Medical
School Program
First year Second year
Coursework
Basic clinical genetics Advanced clinical genetics
Molecular genetics I Molecular genetics II
Gene expression Embryology
Molecular cytogenetics Fetal ultrasound
Metabolic diseases Statistics for genetic counselors
Genetic screening Medical psychology
Seminar in medical genetics I Seminar in medical genetics II
Genetic Lab technologies Decision-Making course
Seminar on research in genetic counseling
Workshop in genetic counseling (includes
role-playing)
Ethics in modern genetics
Clinical training
The clinical work is all observational: 60–70
sessions of general genetics cases including
pediatrics, prenatal, and preimplantation genetic
diagnosis (PGD). Students submit 30 clinic reports
that focus on the genetic condition and the
information that had been communicated to the
clients and submit a comprehensive paper on one
of the prenatal conditions.
The clinical work is mostly observational with
an emphasis on counseling techniques: 60–70
sessions of general genetics and cancer genetics
cases. Students take pedigrees and practice writing
summary letters. They submit summaries for 20
sessions commenting on the counseling and the
decision-making.
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geneticist still has to be responsible. In addition, although the
profession has been defined and recognized by the Ministry of
Health, in most of the hospitals, genetic counselors are not
being employed under this professional title; instead, they are
hired as “lab workers,” “academics in social sciences and
humanities,” and other non-specific titles. This further impacts
genetic counselors’ status and salaries.
It is of note that genetic counselors in Israel are licensed but
currently cannot work with non-geneticists, whereas in the
United States, genetic counselors can work with non-
geneticists but may not be licensed if their state does not have
a licensure law. Historically, in the United States, genetic coun-
selors first worked with clinical geneticists in traditional genet-
ics clinics – pediatric, prenatal, adult and general genetics
clinics. In the 1990s, genetic counselors’ work began expand-
ing into diverse practice settings and specialties; many counse-
lors work with non-geneticists, including cardiologists,
neurologists, obstetricians/gynecologists, pediatricians, oncolo-
gists and perinatologists/maternal-fetal medicine specialists
(Balkite and Smith 1999; Walker 1999; National Society of
Genetic Counselors Professional Status Survey 2012). In
regards to genetic counselor supervision, NSGC model licen-
sure language specifically does not stipulate a supervision
requirement except for genetic counselors with provisional/-
temporary licenses (http://www.nsgc.org/Advocacy/State
LicensureforGeneticCounselors/ModelLicensureProvisions/
tabid/324/Default.aspx).
Given advances in genetic testing and increasing popu-
lation needs for genetic services, Israeli genetic counselors
want to be recognized as an independent profession and
expand their practice settings and roles. This includes the
ability to work in community clinics and to work with non-
geneticists and clinicians in other specialties (e.g. obstetri-
cians/gynecologists, oncologists, neurologists). Since 2009,
genetic counselors have been discussing these role and
practice expansion issues at their IAGC meetings and have
surveyed members. In addition, the IAGC has initiated dis-
cussions with the Ministry of Health, advocating for genetic
counselor autonomy and status enhancement.
In December 2012, the Ono Academic College (Kiryat Ono,
Israel), held a conference entitled: “Genetic Counseling in
Israel: Past, Present and Future” (www.ono.ac.il/24712/?
lang=en) that was attended by genetic counselors, physicians
and representatives from the Ministry of Health. Genetic coun-
selors highlighted “gaps” in the field of genetic counseling: 1)
between the increasing need for genetic counseling services and
the limited working opportunities due to the restrictions posed
by the Ministry of Health on genetic counselors’ employment
and 2) between the high competence of genetic counselors and
their low status in the medical system. It was decided at this
conference that given these gaps, the Ministry of Health will be
asked again to reconsider the regulation and supervision
requirements for genetic counselors.
Conclusion
This is the first article to summarize the history and training
of Master level genetic counselors in Israel. Genetic coun-
selors with Master’s degrees have practiced in Israel for
almost 40 years and most genetic counselors have received
their training in Israel. While much has been achieved in
establishing genetic counseling services in Israel, expanding
genetic counselors practice into specialty areas and commu-
nity health settings and their work opportunities with other
clinicians will better position Israel to realize the promise of
genomic medicine.
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